» Articles » PMID: 22140591

Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference

Overview
Date 2011 Dec 6
PMID 22140591
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dengue infection ranks as one of the most significant viral diseases of the globe. Currently, there is no specific vaccine or antiviral therapy for prevention or treatment. Monocytes/macrophages are the principal target cells for dengue virus and are responsible for disseminating the virus after its transmission. Dengue virus enters target cells via receptor-mediated endocytosis after the viral envelope protein E attaches to the cell surface receptor. This study aimed to investigate the effect of silencing the CD-14 associated molecule and clathrin-mediated endocytosis using siRNA on dengue virus entry into monocytes.

Methodology/principal Findings: Gene expression analysis showed a significant down-regulation of the target genes (82.7%, 84.9 and 76.3% for CD-14 associated molecule, CLTC and DNM2 respectively) in transfected monocytes. The effect of silencing of target genes on dengue virus entry into monocytes was investigated by infecting silenced and non-silenced monocytes with DENV-2. Results showed a significant reduction of infected cells (85.2%), intracellular viral RNA load (73.0%), and extracellular viral RNA load (63.0%) in silenced monocytes as compared to non-silenced monocytes.

Conclusions/significance: Silencing the cell surface receptor and clathrin mediated endocytosis using RNA interference resulted in inhibition of the dengue virus entry and subsequently multiplication of the virus in the monocytes. This might serve as a novel promising therapeutic target to attenuate dengue infection and thus reduce transmission as well as progression to severe dengue hemorrhagic fever.

Citing Articles

Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection.

Gutierrez-Barbosa H, Medina-Moreno S, Perdomo-Celis F, Davis H, Chua J, Zapata J Pathogens. 2024; 13(8).

PMID: 39204240 PMC: 11357684. DOI: 10.3390/pathogens13080639.


A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection.

Bahojb Mahdavi S, Jebelli A, Aghbash P, Baradaran B, Amini M, Oroojalian F Med Res Rev. 2024; 45(2):349-425.

PMID: 39185567 PMC: 11796338. DOI: 10.1002/med.22073.


A Preliminary Investigation on the Antiviral Activities of the Philippine Marshmint (Mentha arvensis) Leaf Extracts against Dengue Virus Serotype 2 In Vitro.

Victoriano-Belvis A, Lao R, Morato M, Repotente E, Saclauso S, Inovejas S Kobe J Med Sci. 2022; 67(3):E98-E111.

PMID: 35367996 PMC: 9673882.


Elevated TNF-α Induces Thrombophagocytosis by Mononuclear Cells in ex vivo Whole-Blood Co-Culture with Dengue Virus.

Satria R, Jhan M, Chen C, Tseng P, Wang Y, Lin C J Inflamm Res. 2022; 15:1717-1728.

PMID: 35282270 PMC: 8906901. DOI: 10.2147/JIR.S356742.


Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses.

Ka S, Merindol N, Sow A, Singh A, Landelouci K, Plourde M Antimicrob Agents Chemother. 2021; 65(9):e0039821.

PMID: 34152811 PMC: 8370201. DOI: 10.1128/AAC.00398-21.


References
1.
Uprichard S . The therapeutic potential of RNA interference. FEBS Lett. 2005; 579(26):5996-6007. PMC: 7094730. DOI: 10.1016/j.febslet.2005.08.004. View

2.
Ibanez C, Schrier R, Ghazal P, Wiley C, Nelson J . Human cytomegalovirus productively infects primary differentiated macrophages. J Virol. 1991; 65(12):6581-8. PMC: 250717. DOI: 10.1128/JVI.65.12.6581-6588.1991. View

3.
Miller J, de Wet B, deWet B, Martinez-Pomares L, Radcliffe C, Dwek R . The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008; 4(2):e17. PMC: 2233670. DOI: 10.1371/journal.ppat.0040017. View

4.
Ang F, Wong A, Ng M, Chu J . Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J. 2010; 7:24. PMC: 2825209. DOI: 10.1186/1743-422X-7-24. View

5.
Orr S, Tobias P . LPS and LAM activation of the U373 astrocytoma cell line: differential requirement for CD14. J Endotoxin Res. 2000; 6(3):215-22. View